Grapefruit USA, Inc. (GPFT) Stock Analysis

Grapefruit USA, Inc. (GPFT) Healthcare & Pipeline Overview

Grapefruit USA, Inc. is a Delaware-based healthcare company specializing in the development and distribution of cannabis-related goods, primarily targeting the California market. Its flagship product, Hourglass, is a proprietary sustained-release THC and CBD topical cream, exclusively sold through its dedicated online platform, positioning the company within the evolving specialty cannabis sector.

What Is the Investment Thesis for GPFT?

Grapefruit USA, Inc. presents an investment profile centered on its participation in the specialized segment of the cannabis industry, specifically through its proprietary topical product, Hourglass. The company's focus on the California market, a significant and mature regulated cannabis economy, provides a foundational operating environment. The sustained-release THC and CBD topical cream, Hourglass, represents a differentiated product offering within the wellness and therapeutic cannabis space, potentially appealing to consumers seeking localized, non-ingestible cannabinoid delivery methods. Growth catalysts include the potential for increased market penetration of Hourglass within California through enhanced online sales strategies and brand recognition. Further opportunities could arise from the broader trend of increasing acceptance and legalization of cannabis products, which may facilitate future geographic expansion beyond California, contingent on regulatory developments. However, the company's current market capitalization of $0.00B and its OTC Other listing signify a highly speculative investment with inherent volatility and liquidity risks. The ability to secure adequate funding for operational expansion and product development, alongside successfully navigating the complex and evolving regulatory landscape of the cannabis industry, will be critical value drivers. Investors should closely monitor the company's financial performance, product development pipeline, and strategic initiatives to expand its market presence.

Based on FMP financials and quantitative analysis

GPFT Key Highlights

Market Capitalization: $0.00B, indicating a micro-cap company with potentially high volatility.

• Beta: -0.09, suggesting a low correlation with broader market movements, though this can be highly variable for micro-cap OTC stocks.
• Dividend Yield: None, as the company does not currently distribute dividends.
• Product Focus: Specialization in Hourglass, a sustained-release THC and CBD topical cream, targeting a specific niche within the cannabis wellness market.
• Geographic Concentration: Primary operational focus on the California market, leveraging its established regulatory framework.

Who Are GPFT's Competitors?

GPFT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are GPFT's Key Strengths?

Proprietary sustained-release THC and CBD topical cream (Hourglass).

• Exclusive online sales platform for direct consumer engagement.
• Focus on the large and established California cannabis market.
• Specialization in a niche segment (topical applications) of the cannabis industry.

What Are GPFT's Weaknesses?

Very low market capitalization ($0.00B) indicating limited financial resources.

• OTC Other listing, implying high volatility and limited liquidity.
• Reliance on a single flagship product (Hourglass) for revenue generation.
• Small employee base (9 employees) potentially limiting scalability and operational breadth.

What Could Drive GPFT Stock Higher?

GPFT catalyst: Enhanced Online Sales and Marketing Initiatives: Grapefruit USA, Inc. could implement new digital marketing campaigns or e-commerce platform enhancements to drive increased sales of Hourglass within the California market.

• Such initiatives, if successful, could lead to improved revenue figures and market penetration.
• Regulatory Developments in California: Any favorable changes or clarifications in California's cannabis regulations, particularly those impacting topical products or online sales, could streamline operations or expand market access for Hourglass.
• Product Development and Innovation: Continuous research and development efforts to refine the Hourglass formulation or introduce new complementary topical cannabis products could attract new customers and strengthen the company's market position.
• Broader Cannabis Legalization Trends: The ongoing trend of cannabis legalization at the state level in the U.S. could create future opportunities for geographic expansion, although this would require significant regulatory navigation and capital.

What Are the Key Risks for GPFT?

Financial-distress signal — its Altman Z-Score of -31.30 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
• Funding and Liquidity Challenges: Given its $0.00B market capitalization and OTC Other listing, Grapefruit USA, Inc. faces significant challenges in securing adequate funding for operations, expansion, and product development, potentially leading to operational constraints or dilution.
• Regulatory Uncertainty in Cannabis Industry: The cannabis industry operates under a complex and evolving patchwork of state and federal regulations. Changes in these regulations, particularly at the federal level, could negatively impact the company's operations, market access, or product legality.
• Intense Competition: The cannabis market, even in specialized segments like topicals, is highly competitive with numerous players. Grapefruit USA, Inc. must continuously innovate and differentiate to maintain market share against existing and new entrants.
• Product Concentration Risk: The company's primary reliance on a single flagship product, Hourglass, exposes it to significant risk if demand for this product declines, or if competitors introduce superior alternatives.
• OTC Market Risks: The OTC Other listing inherently carries risks of low liquidity, high volatility, and limited transparency, making the stock highly speculative and potentially difficult to trade.

What Are the Growth Opportunities for GPFT?

• Expansion within California's Regulated Market: Grapefruit USA, Inc. currently focuses on the California market, which is the largest legal cannabis market in the United States. There is substantial opportunity to increase market penetration for its Hourglass topical cream by expanding its online sales reach and potentially exploring additional distribution channels within the state's regulated framework. As consumer awareness of cannabis topicals grows, and as the market matures, the company can capitalize on its established presence to capture a larger share of this specific product segment. The California cannabis market continues to grow, offering a fertile ground for companies with differentiated products to expand their customer base and sales volume over the next 3-5 years.
• Product Line Extension and Innovation: Building upon the proprietary sustained-release technology utilized in Hourglass, Grapefruit USA, Inc. has the opportunity to develop and introduce new cannabis-infused topical products or explore other non-ingestible cannabinoid delivery systems. This could include variations in cannabinoid ratios (e.g., higher CBD, specific minor cannabinoids), different formulations (e.g., balms, lotions, patches), or targeting specific therapeutic applications. Such innovation could broaden its product appeal, attract new customer segments, and enhance its competitive advantage in the specialty cannabis market. This strategy could unfold over a 2-4 year timeline, contingent on research and development cycles.
• Geographic Expansion into New Legal Markets: While currently focused on California, the increasing trend of cannabis legalization across other U.S. states presents significant long-term growth opportunities. As more states establish regulated cannabis markets, Grapefruit USA could strategically evaluate and enter new jurisdictions, leveraging its product development expertise and online sales model. This would require careful navigation of diverse state-specific regulatory frameworks and potential capital investment, but could unlock substantial new revenue streams over a 5-10 year horizon as federal reforms potentially simplify interstate commerce.
• Strategic Partnerships and Brand Collaborations: To accelerate market penetration and product development, Grapefruit USA, Inc. could pursue strategic partnerships with established cannabis distributors, wellness brands, or research institutions. Collaborations could facilitate broader access to distribution networks, enhance brand visibility, or contribute to further scientific validation of its sustained-release technology. Partnering with complementary brands could also introduce Hourglass to new consumer demographics, expanding its market reach more efficiently than organic growth alone. Such partnerships could materialize within the next 1-3 years.
• Leveraging E-commerce and Direct-to-Consumer Model: The exclusive online sales platform for Hourglass provides a direct channel to consumers, offering opportunities for personalized marketing, data collection, and efficient inventory management. By investing in digital marketing, search engine optimization, and customer relationship management (CRM) tools, Grapefruit USA can optimize its e-commerce strategy to reach a wider audience within California and build a strong brand community. Enhancing the online user experience and subscription models could drive recurring revenue and customer loyalty, a growth avenue that can be continuously refined over the short to medium term (1-2 years).

What Threats Does GPFT Face?

• Evolving and complex regulatory landscape in the cannabis industry.
• Intense competition from established and emerging cannabis companies.
• Difficulty in securing adequate funding for growth and operations due to low market cap.
• Potential for new, more effective topical cannabis products from competitors.

What Are GPFT's Competitive Advantages?

• Proprietary Formulation: The sustained-release blend of THC and CBD in Hourglass represents a unique product offering in the topical cannabis market.
• Direct-to-Consumer Channel: Exclusive online sales platform provides control over brand messaging, customer experience, and direct access to consumer data.
• Early Market Entry: Established in 2017, the company has some tenure in the evolving cannabis industry, particularly in California.

What Does GPFT Do?

Grapefruit USA, Inc., headquartered in Wilmington, Delaware, operates within the dynamic cannabis industry, focusing on the development, branding, and distribution of cannabis-related products. Established in 2017, the company initially operated under the name Grapefruit Boulevard Investments, Inc., before officially rebranding to its current corporate identity in January 2020. The core of Grapefruit USA's business model revolves around serving the California market, one of the largest and most established regulated cannabis markets globally. A significant offering in its product portfolio is Hourglass, a distinctive topical cream. This product is formulated with a sustained-release blend of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), designed for localized application. The company leverages a direct-to-consumer strategy for Hourglass, distributing it exclusively through its dedicated online platform. With a lean operational structure, employing 9 individuals, Grapefruit USA, Inc. aims to carve out a niche in the specialty cannabis segment, particularly within the wellness and therapeutic applications of cannabinoids. Its strategic focus on a proprietary topical product and a specific geographic market underscores its approach to navigating the complex and evolving regulatory and competitive landscape of the cannabis sector. The company's evolution from its founding to its current structure reflects an adaptation to market demands and regulatory frameworks within the United States cannabis industry.

What Products and Services Does GPFT Offer?

• Develops and distributes cannabis-related goods.
• Specializes in creating topical cannabis products.
• Offers Hourglass, a proprietary sustained-release THC and CBD topical cream.
• Sells Hourglass exclusively through its dedicated online platform.
• Primarily serves the California market.
• Focuses on the wellness and therapeutic applications of cannabinoids.
• Operates as a drug manufacturer in the specialty and generic segment.

How Does GPFT Make Money?

• Product Development and Sales: Develops proprietary cannabis-infused topical creams, such as Hourglass, and generates revenue directly from their sale.
• Direct-to-Consumer (DTC) E-commerce: Utilizes an exclusive online platform for the distribution of its flagship product, bypassing traditional retail channels to reach customers directly.
• Niche Market Focus: Targets the specialty cannabis market, specifically consumers seeking topical applications of THC and CBD for localized effects.

What Industry Does GPFT Operate In?

Grapefruit USA, Inc. operates within the Healthcare sector, specifically categorized under Drug Manufacturers - Specialty & Generic, due to its focus on cannabis-related goods. The broader cannabis industry is characterized by rapid evolution, driven by increasing legalization trends at the state level in the U.S. and globally. This has led to significant market growth, with projections indicating continued expansion in both medical and recreational segments. Within this landscape, Grapefruit USA positions itself in the specialty segment, focusing on topical applications of cannabinoids rather than traditional ingestibles or inhalables. The competitive environment is fragmented, comprising numerous small to medium-sized enterprises alongside larger, more established multi-state operators (MSOs). Key market trends include a growing consumer preference for diverse product forms, including topicals, tinctures, and edibles, and an increasing emphasis on product formulation, efficacy, and consistent dosing. Grapefruit USA's strategy of offering a proprietary sustained-release topical cream, Hourglass, aims to differentiate it within this crowded market by addressing a specific consumer need for localized cannabinoid delivery. Its exclusive online sales channel further defines its competitive approach within the California market.

Who Are GPFT's Key Customers?

• Consumers in California seeking topical cannabis solutions for wellness or therapeutic purposes.
• Individuals interested in non-ingestible or non-inhalable forms of cannabinoid delivery.
• Customers who value sustained-release formulations for consistent product effects.

The most recent 12 insider filings for Grapefruit USA, Inc. break down as 12 sales and 0 purchases. On net that is roughly 1.1M shares disposed (about $30K), a signal worth weighing alongside the fundamentals.

Return on equity for Grapefruit USA, Inc. stands at 14.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -77.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -22.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.

Grapefruit USA, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -31.30 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Grapefruit USA, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Bradley J. Yourist. GPFT has traded publicly since 2016.

GPFT Financials

GPFT Latest News

No recent news available for GPFT.

GPFT Analyst Consensus

GPFT MoonshotScore

Grapefruit USA, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources